cytosine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Di Tella, S | 1 |
| Lo Monaco, MR | 1 |
| Petracca, M | 1 |
| Zinzi, P | 1 |
| Solito, M | 1 |
| Piano, C | 1 |
| Calabresi, P | 1 |
| Silveri, MC | 1 |
| Bentivoglio, AR | 1 |
| Tanner, C | 1 |
| Marder, K | 1 |
| Eberly, S | 1 |
| Biglan, K | 1 |
| Oakes, D | 1 |
| Shoulson, I | 1 |
| Wang, F | 1 |
| Yang, Y | 1 |
| Lin, X | 1 |
| Wang, JQ | 1 |
| Wu, YS | 1 |
| Xie, W | 1 |
| Wang, D | 1 |
| Zhu, S | 1 |
| Liao, YQ | 1 |
| Sun, Q | 1 |
| Yang, YG | 1 |
| Luo, HR | 1 |
| Guo, C | 1 |
| Han, C | 1 |
| Tang, TS | 1 |
| Villar-Menéndez, I | 1 |
| Blanch, M | 1 |
| Tyebji, S | 1 |
| Pereira-Veiga, T | 1 |
| Albasanz, JL | 1 |
| Martín, M | 1 |
| Ferrer, I | 1 |
| Pérez-Navarro, E | 1 |
| Barrachina, M | 1 |
| Zeng, W | 1 |
| Gillis, T | 1 |
| Hakky, M | 1 |
| Djoussé, L | 1 |
| Myers, RH | 1 |
| MacDonald, ME | 1 |
| Gusella, JF | 1 |
| Morovvati, S | 1 |
| Nakagawa, M | 1 |
| Osame, M | 1 |
| Karami, A | 1 |
| Vuillaume, I | 1 |
| Vermersch, P | 1 |
| Destée, A | 1 |
| Petit, H | 1 |
| Sablonnière, B | 1 |
| Berrios, GE | 1 |
| Wagle, AC | 1 |
| Marková, IS | 1 |
| Wagle, SA | 1 |
| Ho, LW | 1 |
| Rubinsztein, DC | 1 |
| Whittaker, J | 1 |
| Ffrench-Constant, C | 1 |
| Kershaw, A | 1 |
| Rosser, A | 1 |
| Bak, T | 1 |
| Hodges, JR | 1 |
8 other studies available for cytosine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.
Topics: Adenine; Adult; Age of Onset; Child; Cytosine; Guanine; Humans; Huntington Disease; Neurodegenerativ | 2022 |
Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.
Topics: Adenine; Adult; Cytosine; Environment; Female; Follow-Up Studies; Guanine; Humans; Huntingtin Protei | 2018 |
Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease.
Topics: 5-Methylcytosine; Animals; Brain; Corpus Striatum; Cytosine; Disease Models, Animal; DNA Methylation | 2013 |
Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.
Topics: 5-Methylcytosine; 5' Untranslated Regions; Adult; Aged; Aged, 80 and over; Animals; Corpus Striatum; | 2013 |
Genetic analysis of the GRIK2 modifier effect in Huntington's disease.
Topics: 3' Untranslated Regions; Adenine; Age of Onset; Alleles; Cytosine; Exons; Genetic Variation; GluK2 K | 2006 |
Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan.
Topics: Asian People; Cytosine; Female; Gene Frequency; Guanine; Humans; Huntingtin Protein; Huntington Dise | 2008 |
Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
Topics: Adenine; Adult; Age of Onset; Aged; Alleles; Cytosine; Gene Deletion; Genotype; Guanine; Humans; Hun | 1998 |
Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers.
Topics: Adenine; Adult; Age of Onset; Cognition; Cytosine; Female; Genetic Predisposition to Disease; Guanin | 2001 |